J&J to Sell Remaining Stake in Kenvue Spinoff
By Dean Seal
Johnson & Johnson plans to unload its remaining 9.5% stake in Kenvue in a public offering set about a year after it started splitting off the Tylenol and Benadryl maker.
Kenvue said Monday that it will launch a secondary underwritten offering for 182.3 million shares that Johnson & Johnson is providing in a debt-for-equity exchange with Goldman Sachs and JP Morgan.
If sold at Friday's closing price of $20.54, the offering would fetch around $3.75 billion.
Kenvue said that Johnson & Johnson will no longer own any of its stock once the offering is completed.
Johnson & Johnson held an initial public offering for Kenvue a year ago and then sold most of its shares in the company in August.
The healthcare giant previously said it wanted to untangle the consumer-health unit's finances and operations from its prescription-drugs and medical device businesses. The effort followed similar moves by Pfizer and Merck, which sold their consumer-health businesses.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
May 13, 2024 10:06 ET (14:06 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying
-
The 10 Best Companies to Invest in Now